As of 2026-05-27, the EV/EBITDA ratio of Marksans Pharma Ltd (MARKSANS.NS) is 16.31. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. MARKSANS.NS's latest enterprise value is 96,468.76 mil INR. MARKSANS.NS's TTM EBITDA according to its financial statements is 5,913.48 mil INR. Dividing these 2 quantities gives us the above MARKSANS.NS EV/EBITDA ratio.
| Range | Selected | |
| Trailing P/E multiples | 15.3x - 16.4x | 16.2x |
| Forward P/E multiples | 8.8x - 10.7x | 9.0x |
| Fair Price | 149.29 - 221.65 | 186.71 |
| Upside | -32.2% - 0.6% | -15.2% |
| Date | EV/EBITDA |
| 2026-05-22 | 15.67 |
| 2026-05-21 | 16.09 |
| 2026-05-20 | 16.11 |
| 2026-05-19 | 15.99 |
| 2026-05-18 | 16.22 |
| 2026-05-15 | 15.44 |
| 2026-05-14 | 14.99 |
| 2026-05-13 | 14.68 |
| 2026-05-12 | 14.65 |
| 2026-05-11 | 15.13 |
| 2026-05-08 | 14.57 |
| 2026-05-07 | 15.00 |
| 2026-05-06 | 14.58 |
| 2026-05-05 | 13.91 |
| 2026-05-04 | 13.96 |
| 2026-04-30 | 13.61 |
| 2026-04-29 | 13.84 |
| 2026-04-28 | 13.66 |
| 2026-04-27 | 14.02 |
| 2026-04-24 | 13.98 |
| 2026-04-23 | 14.28 |
| 2026-04-22 | 13.15 |
| 2026-04-21 | 13.03 |
| 2026-04-20 | 13.01 |
| 2026-04-17 | 13.20 |
| 2026-04-16 | 13.22 |
| 2026-04-15 | 13.19 |
| 2026-04-13 | 12.98 |
| 2026-04-10 | 13.12 |
| 2026-04-09 | 12.84 |
| 2026-04-08 | 12.79 |
| 2026-04-07 | 12.43 |
| 2026-04-06 | 12.21 |
| 2026-04-02 | 12.30 |
| 2026-04-01 | 12.18 |
| 2026-03-30 | 11.47 |
| 2026-03-27 | 11.85 |
| 2026-03-25 | 12.10 |
| 2026-03-24 | 12.11 |
| 2026-03-23 | 11.66 |
| 2026-03-20 | 12.55 |
| 2026-03-19 | 11.86 |
| 2026-03-18 | 12.31 |
| 2026-03-17 | 11.97 |
| 2026-03-16 | 12.07 |
| 2026-03-13 | 12.23 |
| 2026-03-12 | 12.69 |
| 2026-03-11 | 12.69 |
| 2026-03-10 | 12.84 |
| 2026-03-09 | 12.45 |